Clinical Trial Update: Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial update on reversal of hepatic impairment in hepatitis C patients with early cirrhosis decompensation; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Colorado, Denver | Conditions: Hepatitis C | Phase 3 | Status: TERMINATED | Results posted: 2021-09-13